Prevention and Control of Schistosomiasis and Soil-transmitted Helminthiasis : Report of a WHO Expert Committee.
This report contains the recommendations of a WHO Expert Committee convened to consider the prevention and control of schistosomiasis and soil-transmitted helminth infections. Although these infections remain major public health concerns in many parts of the world, particularly in the poorest develo...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Geneva :
World Health Organization,
2002.
|
Colección: | Technical Report Series.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Contents; 1. INTRODUCTION; 1.1 Schistosomiasis; 1.2 Evolution of the strategic approach to control schistosomiasis; 1.3 Resolution WHA54.19 on schistosomiasis and soil-transmitted helminth infections; 1.4 Recommendations on morbidity control; 1.5 Countries, areas and population groups eligible for preventive chemotherapy; 1.6 From control to elimination; 1.7 Aim of this document; 2. PROGRESS REPORT 2001-2011; 2.1 Performance; 2.2 Impact; 2.3 Challenges; 2.3.1 Political commitment; 2.3.2 Coordination; 2.3.3 Communication; 2.3.4 Technical capacity; 2.3.5 Monitoring and evaluation
- 2.3.6 Operational guidance2.3.7 Complementary public-health interventions; 3. ENDEMIC COUNTRIES AND THEIR CLASSIFICATION; 3.1 Status of countries endemic for schistosomiasis; 3.2 Progression towards elimination of schistosomiasis; 3.3 Resolution WHA65.21 on the elimination of schistosomiasis; 4. STRATEGIC PLAN 2012-2020; 4.1 Background; 4.2 Vision, goals and objectives; 4.3 Control of morbidity; 4.4 Elimination of schistosomiasis as a public-health problem; 4.5 Interruption of transmission; 4.6 Verification of elimination of schistosomiasis transmission; 4.7 Post-elimination surveillance
- 4.8 Strategic approaches to address challenges to schistosomiasis control4.8.1 Political commitment; 4.8.2 Coordination; 4.8.3 Communication; 4.8.4 Technical capacity; 4.8.5 Monitoring and evaluation; 4.8.6 Operational guidance; 4.8.7 Complementary public-health interventions; 4.9 Milestones; 5. REGIONAL HIGHLIGHTS; 5.1. African Region; 5.2 Region of the Americas; 5.3 Eastern Mediterranean Region; 5.4 European Region; 5.5 South-East Asia Region; 5.6 Western Pacific Region; 6. PROJECTED NEEDS OF PRAZIQUANTEL; 6.1. Population requiring preventive chemotherapy for schistosomiasis
- 6.2 Projected need of praziquantel, 2012-2020 and beyond6.2.1 Scale-up and down; 6.2.2 Population growth; 6.2.3 Procurement data for 2011 and 2012; REFERENCES; ANNEXES; Annex I: Chronology of WHO official publication on schistosomiasis; Annex II: Issues of the Weekly Epidemiological Record on schistosomiasis; Annex III: Resolutions of the World Health Assembly on schistosomiasis; Annex IV: Revised estimates of people requiring preventive chemotherapy for schistosomiasis; Annex V: List of schistosomiasis-endemic countries according to WHO Technical Report Series No. 830